Related references
Note: Only part of the references are listed.Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results
D. Simon et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Thyrotropin suppressive therapy in thyroid carcinoma: What are the targets?
G. Brabant
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Increased iodine uptake in thyroid carcinoma after treatment with sodium butyrate and decitabine (5-Aza-dC)
Matthew J. Provenzano et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2007)
Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor
Zhilong Ai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid
Zijuan Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Arsenic trioxide (As2O3) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo
Jingjing Zhang et al.
GYNECOLOGIC ONCOLOGY (2006)
Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism
SY Woo et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2006)
Dithiol compounds at low concentrations increase arsenite toxicity
KY Jan et al.
TOXICOLOGICAL SCIENCES (2006)
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells
X Cui et al.
HUMAN PATHOLOGY (2006)
Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors
C Puppin et al.
ENDOCRINOLOGY (2005)
Expression of pendrin in benign and malignant human thyroid tissues
J Skubis-Zegadlo et al.
BRITISH JOURNAL OF CANCER (2005)
Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate
N Knoll et al.
TOXICOLOGICAL SCIENCES (2005)
Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture
E Fröhlich et al.
ENDOCRINE-RELATED CANCER (2005)
The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells
M Mandal et al.
BRITISH JOURNAL OF CANCER (2005)
Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy
RJ Griffin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Functional characterization of pendrin in a polarized cell system - Evidence for pendrin-mediated apical iodide efflux
MP Gillam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide
TC Hour et al.
ANTI-CANCER DRUGS (2004)
Immunohistochemical detection of activated caspases in apoptotic hepatocytes in rat liver
VS Eckle et al.
TOXICOLOGIC PATHOLOGY (2004)
Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines
K Davison et al.
LEUKEMIA (2003)
The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2003)
Differential influences of various arsenic compounds on glutathione redox status and antioxidative enzymes in porcine endothelial cells
JY Yeh et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma
J Vuky et al.
INVESTIGATIONAL NEW DRUGS (2002)
Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3)
YJ Chun et al.
FEBS LETTERS (2002)
Arsenic trioxide and breast cancer: Analysis of the apoptotic, differentiative and immunomodulatory effects
G Baj et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
The sensitivity of digestive tract tumor cells to As2O3 is associated with the inherent cellular level of reactive oxygen species
F Gao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Sodium iodide symporter and pendrin expression in human thyroid tissues
C Mian et al.
THYROID (2001)
Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon
CD Davis et al.
JOURNAL OF NUTRITION (2000)
All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1
J Kurebayashi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Expression of pendrin and the Pendred Syndrome (PDS) gene in human thyroid tissues
JM Bidart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Retinoic acid redifferentiation therapy for thyroid cancer
C Schmutzler et al.
THYROID (2000)
Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
IE Royaux et al.
ENDOCRINOLOGY (2000)
Share Paper
